Positive Phase 2 clinical trial results for the Lyme disease vaccine candidate (VLA15) in the pediatric population have just been announced by Pfizer and Valneva. VLA15 is currently the only Lyme disease vaccine candidate in clinical development, and is the first clinical study to enroll children aged 5 to 17 years old. This phase 2 […]
The Department of Defense Congressionally Directed Medical Research Program (CDMRP) published a news release alerting Lyme & other tick-borne diseases researchers of anticipated FY22 monies that may become available through the program so that researchers can plan and develop possible grant submissions. The CDMRP-TBDRP states that “Applicants are particularly encouraged to submit applications focused on […]
On April 9, 2022, New York Governor, Kathy Hochul (D), granted New York licensed Nurse practitioners (NPs) the ability to practice independently when she signed the State budget into law. NPs that have greater than 36,000 hours of experience may now practice fully without a formal relationship and agreement with a medical doctor. According to […]
The FDA has just announced that they plan to postpone their scheduled advisory committee meeting on Pfizer’s COVID-19 vaccine for children ages 6 months to 4 years. They do not expect to reconvene for a few more months pending additional data required to move forward. A two-dose vaccine series failed to meet “immunobridging” criteria […]
In a February 4, 2022 news release Valneva/Pfizer reported positive Phase 2 data findings for their Lyme disease vaccine candidate, VLA15. According to the news release, findings of the Phase 2 trial show there is value in adding a third dose of vaccine. In the Phase 2 clinical trial, researchers found a stronger immune response […]
For more information on this issue go to Go to LDA’s ILADS has launched a Doctor-Patient Relationship Importance Campaign ILADS Campaign Highlights Importance of Doctor-Patient Relationship in Treating Chronic Diseases The International Lyme and Associated Diseases Society (ILADS) is running a powerful public awareness campaign to highlight the importance of doctor-patient relationships in the treatment […]
B. mayonii is a relatively new species of Lyme causing pathogen that has only been detected in the Upper Midwest of the United States. It is considered a rare cause of Lyme disease and may frequently go undetected. Mayo laboratories recently observed that spirochetes of the pathogen Borrelia mayonii can occasionally be visualized on routine […]
In a recent press release, researchers in the Perelman School of Medicine at the University of Pennsylvania have discovered that T-cells, which are important fighters in the immune system, not only become “exhausted” from fighting cancer or viral infections, but they remain “exhausted” many weeks after these exposures. According to the press release, “exhaustion” leaves […]
In a letter to physicians, the Maryland Department of Health (MDH) warns doctors to pay attention to Lyme which is the most frequently diagnosed tick-borne disease (TBD) in Maryland residents (1400 cases 2019). The MDH also cautions them to report other TBDs, which it specifically names. The letter also points out the similarities of Lyme […]
According to the Tulane news, a three-year, $4.8 million initiative funded by The Steven and Alexandra Cohen Foundation, will establish the Bartonella Research Consortium with the goal of developing a novel treatment for bartonellosis. There are over 40 known Bartonella species/subspecies and at least 17 of these species/subspecies have been associated with a spectrum of debilitating […]